BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 16580084)

  • 1. Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation.
    Unitt E; Marshall A; Gelson W; Rushbrook SM; Davies S; Vowler SL; Morris LS; Coleman N; Alexander GJ
    J Hepatol; 2006 Aug; 45(2):246-53. PubMed ID: 16580084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma.
    Mathai AM; Kapadia MJ; Alexander J; Kernochan LE; Swanson PE; Yeh MM
    Am J Surg Pathol; 2012 Jul; 36(7):980-6. PubMed ID: 22446942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.
    Yang XH; Yamagiwa S; Ichida T; Matsuda Y; Sugahara S; Watanabe H; Sato Y; Abo T; Horwitz DA; Aoyagi Y
    J Hepatol; 2006 Aug; 45(2):254-62. PubMed ID: 16600416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Sasaki A; Tanaka F; Mimori K; Inoue H; Kai S; Shibata K; Ohta M; Kitano S; Mori M
    Eur J Surg Oncol; 2008 Feb; 34(2):173-9. PubMed ID: 17928188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients.
    Yang ZQ; Yang ZY; Zhang LD; Ping-Bie ; Wang SG; Ma KS; Li XW; Dong JH
    Hum Immunol; 2010 Dec; 71(12):1180-6. PubMed ID: 20870003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ
    Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.
    Gao Q; Qiu SJ; Fan J; Zhou J; Wang XY; Xiao YS; Xu Y; Li YW; Tang ZY
    J Clin Oncol; 2007 Jun; 25(18):2586-93. PubMed ID: 17577038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation.
    Löhe F; Angele MK; Rentsch M; Graeb C; Gerbes A; Löhrs U; Beuers U; Jauch KW
    Clin Transplant; 2007; 21(6):696-701. PubMed ID: 17988261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma.
    Gao Q; Zhou J; Wang XY; Qiu SJ; Song K; Huang XW; Sun J; Shi YH; Li BZ; Xiao YS; Fan J
    Ann Surg Oncol; 2012 Feb; 19(2):455-66. PubMed ID: 21792513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
    Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
    Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score.
    Marelli L; Grasso A; Pleguezuelo M; Martines H; Stigliano R; Dhillon AP; Patch D; Davidson BR; Sharma D; Rolles K; Burroughs AK
    Ann Surg Oncol; 2008 Dec; 15(12):3503-11. PubMed ID: 18777193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study.
    Grasso A; Stigliano R; Morisco F; Martines H; Quaglia A; Dhillon AP; Patch D; Davidson BR; Rolles K; Burroughs AK
    Transplantation; 2006 Jun; 81(11):1532-41. PubMed ID: 16770242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection.
    Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Sun TW; Zhou J; Shi YH; Yang XR; Jin JJ; Cheng YF; Fan J; Qiu SJ
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1312-9. PubMed ID: 22432916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells.
    Lin SZ; Chen KJ; Xu ZY; Chen H; Zhou L; Xie HY; Zheng SS
    Cancer Prev Res (Phila); 2013 Jun; 6(6):594-602. PubMed ID: 23599540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of cell-cycle modulators to predict vascular invasion and recurrence after surgical treatment of hepatocellular carcinoma.
    Ramos E; Lladó L; Serrano T; Figueras A; Lastra R; Torras J; Figueras J; Rafecas A; Fabregat J
    Transplantation; 2006 Sep; 82(6):753-8. PubMed ID: 17006321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
    Zou WL; Zang YJ; Chen XG; Shen ZY
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences].
    Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foxp3+ regulatory T cells are associated with the natural history of chronic hepatitis B and poor prognosis of hepatocellular carcinoma.
    Wang F; Jing X; Li G; Wang T; Yang B; Zhu Z; Gao Y; Zhang Q; Yang Y; Wang Y; Wang P; Du Z
    Liver Int; 2012 Apr; 32(4):644-55. PubMed ID: 22118340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.